Stay updated on Dara-CyBorD in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Dara-CyBorD in Myeloma: Clinical Trial page.

Latest updates to the Dara-CyBorD in Myeloma: Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor backend/template update with no changes to the study content or user-facing information.SummaryDifference0.0%

- Check13 days agoChange DetectedRemoved the 'Multiple myeloma' entry and the 'MedlinePlus Genetics' related topics from the page.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded the topic 'Multiple myeloma' and the related topic 'MedlinePlus Genetics' to the page. This enhances disease-specific navigation and access to related educational resources.SummaryDifference0.1%

- Check34 days agoChange DetectedSite updated to Revision: v3.4.2. The legacy funding notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a global funding notice and a software revision (Revision: v3.4.1). Removed 'Multiple myeloma' and 'MedlinePlus Genetics' from related topics (Revision: v3.4.0).SummaryDifference0.5%

- Check48 days agoChange DetectedGlossary display and related topic links (Multiple Myeloma, MedlinePlus Genetics) were added, while versioning/QC notes (Last Update Submitted that Met QC Criteria, Revision: v3.4.0) were updated and FEAR Act data references adjusted.SummaryDifference0.3%

Stay in the know with updates to Dara-CyBorD in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-CyBorD in Myeloma: Clinical Trial page.